Twist Bioscience (TWST) Raw Materials (2018 - 2026)

Twist Bioscience (TWST) has reported Raw Materials for 9 consecutive years, with $27.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Raw Materials rose 54.61% year-over-year to $27.1 million in Q2 2026; TTM through Jun 2026 was $27.1 million, a 54.61% increase from a year earlier, with the FY2025 full-year figure at $20.2 million, up 16.6% from the prior year.
• Raw Materials was $27.1 million for Q2 2026 at Twist Bioscience, up from $25.5 million in the prior quarter.
• Over five years, Raw Materials peaked at $33.6 million in Q1 2023 and troughed at $14.3 million in Q1 2025.
• A 5-year average of $24.8 million and a median of $25.1 million in 2025 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials surged 180.8% in 2022 and plunged 35.92% in 2024, its largest moves.
• Over 5 years, Raw Materials stood at $33.6 million in 2022, then retreated by 29.22% to $23.8 million in 2023, then slumped by 32.51% to $16.0 million in 2024, then surged by 53.86% to $24.7 million in 2025, then advanced by 9.67% to $27.1 million in 2026.
• The last three Raw Materials figures came in at $27.1 million (Q2 2026), $25.5 million (Q1 2026), and $24.7 million (Q4 2025), per Business Quant data.